Şunu aradınız:: display method for color sequential display (Danca - Fince)

method for establishment of eyellipse for driver’s eye location
method for establishment of eyellipses for driver’s eye location.

grønthe blue channel for colors histogram mode
vihreäthe blue channel for colors histogram mode

farver: the red channel for colors histogram mode
värit: the red channel for colors histogram mode

referencemetoden til måling af ozon er den, der er beskrevet i en 14625:2005 »ambient air quality — standard method for the measurement of the concentration of ozone by ultraviolet photometry«.
otsonin mittaamisessa käytettävä vertailumenetelmä on kuvattu standardissa en 14625:2005 ”ambient air quality – standard method for the measurement of the concentration of ozone by ultraviolet photometry”.

adjustment for baseline covariates points to consider on the use of statistical methods for flexible design and analysis of confirmatory clinical trials points to consider on clinical pharmacokinetic investigation of the pharmacokinetics of peptides and proteins note for guidance on the evaluation of the pharmacokinetics of medicinal products in patients with impaired renal function points to consider on the evaluation of the pharmacokinetics of medicinal products in the paediatric population note for guidance on the evaluation of the pharmacokinetics of medicinal products in patients with hepatic impairment note for guidance on clinical investigation of medicinal products for the treatment of psoriasis points to consider on allergic rhino- conjuctivitis addendum to the note for guidance on modified release oral and transdermal dosage forms:
adjustment for baseline covariates points to consider on the use of statistical methods for flexible design and analysis of confirmatory clinical trials points to consider on clinical pharmacokinetic investigation of the pharmacokinetics of peptides and proteins note for guidance on the evaluation of the pharmacokinetics of medicinal products in patients with impaired renal function points to consider on the evaluation of the pharmacokinetics of medicinal products in the paediatric population note for guidance on the evaluation of the pharmacokinetics of medicinal products in patients with hepatic impairment note for guidance on clinical investigation of medicinal products for the treatment of psoriasis points to consider on allergic rhino- conjuctivitis addendum to the note for guidance on modified release oral and transdermal dosage forms: